| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.22 | 2e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.27 | 4e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.22 | 8e-07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.23 | 4e-06 |